Losen, Mario http://orcid.org/0000-0002-9761-0002
Labrijn, Aran F. http://orcid.org/0000-0001-9239-8439
van Kranen-Mastenbroek, Vivianne H.
Janmaat, Maarten L.
Haanstra, Krista G. http://orcid.org/0000-0002-7654-5096
Beurskens, Frank J.
Vink, Tom
Jonker, Margreet
‘t Hart, Bert A.
Mané-Damas, Marina
Molenaar, Peter C.
Martinez-Martinez, Pilar
van der Esch, Eline
Schuurman, Janine http://orcid.org/0000-0002-9738-9926
de Baets, Marc H.
Parren, Paul W. H. I. http://orcid.org/0000-0002-4365-3859
Article History
Received: 20 September 2016
Accepted: 28 March 2017
First Online: 20 April 2017
Competing Interests
: These authors have a financial interest in Genmab: A.F.L., M.J., F.J.B., T.V., J.S. and P.W.H.I.P. have stock and/or warrants. M.L., P.M-M., J.S., M.H.d.B., and P.W.H.I.P own patent rights to the concept presented in this study. A.F.L., T.V., J.S., F.J.B., and P.W.H.I.P own patent rights to the IgG4Δhinge format presented in this study.